Inventor · disambiguated record
Lin Yan
Also filed as: YAN LIN
29 granted patents·15 pending applications·380 citations·filing 1997–2023
96Inventor score
Files withMERCK SHARP & DOHME15MERCK SHARP & DOHME LLC7BRISTOL MYERS SQUIBB CO6ALI AMJAD5FENG DANQING2
Top patents by PatentIndex Score
44 records- 0197US7005436B2Heterocyclo inhibitors of potassium channel functionICAGEN INC·Filed 2003·Granted Feb 28, 2006·149 cites·15 claims
- 0295US7157451B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 2, 2007·70 cites·15 claims
- 0394US6706720B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Mar 16, 2004·60 cites·21 claims
- 0488US7999107B2Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2008·Granted Aug 16, 2011·13 cites·16 claims
- 0588US7202253B2Cycloalkyl inhibitors of potassium channel functionICAGEN INC·Filed 2004·Granted Apr 10, 2007·27 cites·9 claims
- 0687US10183981B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2018·Granted Jan 22, 2019·5 cites·6 claims
- 0784US9427475B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Aug 30, 2016·5 cites·4 claims
- 0883US7605171B2(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonistsMERCK & CO INC·Filed 2004·Granted Oct 20, 2009·27 cites·15 claims
- 0982US10017556B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 10, 2018·3 cites·10 claims
- 1082US7582654B2Heterocyclo inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 1, 2009·4 cites·4 claims
- 1179US11041009B2Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetesMERCK SHARP & DOHME·Filed 2018·Granted Jun 22, 2021·2 cites·6 claims
- 1279US8623846B2Diazeniumdiolate cyclohexyl derivativesALI AMJAD·Filed 2011·Granted Jan 7, 2014·2 cites·15 claims
- 1378US10689430B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2017·Granted Jun 23, 2020·1 cites·6 claims
- 1474US7541362B2Heterocyclic dihydropyrimidine compoundsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 2, 2009·1 cites·8 claims
- 1572US10800827B2Insulin receptor partial agonistsMERCK SHARP & DOHME·Filed 2018·Granted Oct 13, 2020·0 cites·4 claims
- 1672US8648058B2Diazeniumdiolate cyclopentyl derivativesALI AMJAD·Filed 2011·Granted Feb 11, 2014·2 cites·18 claims
- 1772US8361994B2Primary amine diazeniumdiolate heterocyclic derivativesMERCK SHARP & DOHME·Filed 2012·Granted Jan 29, 2013·2 cites·32 claims
- 1870US8119806B2Cicletanine derivativesALI AMJAD·Filed 2009·Granted Feb 21, 2012·1 cites·12 claims
- 1965US2009312307A1Heterocyclo inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2062US2023365646A1Azide insulin analoguesMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2158US2007142333A1Cycloalkyl inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 2257US9889205B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME·Filed 2016·Granted Feb 13, 2018·0 cites·2 claims
- 2357US9265774B2Methods, compounds and pharmaceutical compositions for treating anxiety and mood disordersSTONE ERIC A·Filed 2012·Granted Feb 23, 2016·1 cites·3 claims
- 2457US2025051416A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2557US2023310551A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2657US2024294596A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2756US2025034211A1C-terminal extended p53 activator crosslinked peptidomimetic macrocycles against mdm2/mdmxMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2856US2025042961A1P53 peptidomimetic macrocyclesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2956US2023105982A1Insulin-incretin conjugatesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 3052US2004072880A1Cycloalkyl inhibitors of potassium channel functionFiled 2003·Application pending·0 cites
- 3151US2022273770A1Glucose-responsive insulin conjugatesFENG DANQING·Filed 2020·Application pending·0 cites
- 3249US12427187B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME LLC·Filed 2020·Granted Sep 30, 2025·0 cites·2 claims
- 3348US6040433ASulfinyl hexose derivatives useful for glycosylationUNIV PRINCETON·Filed 1997·Granted Mar 21, 2000·5 cites·12 claims
- 3448US2021163568A1Azide insulin analoguesMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 3547US11820805B2Conjugate based systems for controlled insulin deliveryMERCK SHARP & DOHME·Filed 2018·Granted Nov 21, 2023·0 cites·3 claims
- 3646US11058775B2Insulin dimer-incretin conjugatesMERCK SHARP & DOHME·Filed 2017·Granted Jul 13, 2021·0 cites·22 claims
- 3746US8377911B2DiureticsMERCK SHARP & DOHME·Filed 2010·Granted Feb 19, 2013·0 cites·8 claims
- 3846US8354394B2DiureticsMERCK SHARP & DOHME·Filed 2010·Granted Jan 15, 2013·0 cites·9 claims
- 3944US9272987B2Diazeniumdiolate cyclohexyl derivativesALI AMJAD·Filed 2012·Granted Mar 1, 2016·0 cites·15 claims
- 4044US7659294B22-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonistsMERCK & CO INC·Filed 2005·Granted Feb 9, 2010·0 cites·11 claims
- 4142US2018110863A1Glucose-responsive insulin conjugatesFENG DANQING·Filed 2016·Application pending·0 cites
- 4240US2006128726A1Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulationsWANG XUEBAO·Filed 2005·Application pending·0 cites
- 4338US9108920B2Diazeniumdiolate heterocyclic derivativesALI AMJAD·Filed 2011·Granted Aug 18, 2015·0 cites·21 claims
- 4438US2019175744A1Insulin-incretin conjugatesPALANI ANANDAN·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lin Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →